Duck Enteritis Virus VP16 Antagonizes IFN-β-Mediated Antiviral Innate Immunity

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Duck enteritis virus (DEV) establishes lifelong latent infections by evading host innate immunity.
• Mechanisms by which DEV escapes innate immune responses remain largely unelucidated.

Purpose of the Study:

• To identify viral factors involved in DEV's evasion of duck innate immunity.
• To investigate the role of viral protein VP16 in suppressing interferon-beta (IFN-β) production.

Main Methods:

• Ectopic expression of VP16 in duck embryo fibroblast (DEF) cells.
• Analysis of duIFN-β promoter activity and mRNA transcription of IFN-β and interferon-stimulated genes (ISGs).
• Coimmunoprecipitation (co-IP) and indirect immunofluorescence assay (IFA) to determine protein interactions.

Main Results:

• VP16 significantly downregulates duIFN-β production and inhibits IFN-β mRNA transcription.
• VP16 suppresses the transcription of ISGs, including Mx and OASL.
• The anti-interferon activity of VP16 resides in its N-terminus and involves direct binding to duck IRF7 (duIRF7), not duck IRF1 (duIRF1).

Conclusions:

• Viral protein VP16 is a key factor in DEV's immune evasion strategy.
• VP16 inhibits the duck interferon response by targeting duIRF7, thereby facilitating viral persistence.